LLY logo Eli Lilly and Company +
Eli Lilly and Company
+

Eli Lilly and Company (LLY) Business News

Track Eli Lilly and Company in real time with a live news feed covering Eli Lilly and Company stock news, official press releases, company announcements, and an archive of historical Eli Lilly and Company news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now

The Motley Fool

12:00 PM | Monday | May 18, 2026

news photo
Loading...

Shares of Pfizer, Novo Nordisk, and PDD Holdings trade at incredibly low valuations right now. These stocks are trading at significant discounts relative to their future earnings.

Read full article redirect
12:00 PM | Monday | May 18, 2026

3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now

The Motley Fool

Shares of Pfizer, Novo Nordisk, and PDD Holdings trade at incredibly low valuations right now. These stocks are trading at significant discounts relative to their future earnings.

Read full article arrow
News Thumbnail
10:00 AM | Monday | May 18, 2026

Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference

PRNewsWire

INDIANAPOLIS, May 18, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 28, 2026. Daniel M. Skovronsky, M.D.

Read full article arrow
News Thumbnail
9:43 AM | Monday | May 18, 2026

US Supreme Court turns away Eli Lilly's challenge to whistleblower law

Reuters

The U.S. Supreme Court declined on Monday to hear ​a challenge by drugmaker Eli Lilly to a Civil War-era whistleblower law that has recovered ‌billions of dollars by allowing private individuals to bring fraud lawsuits on behalf of the federal government.

Read full article arrow
News Thumbnail
8:17 AM | Monday | May 18, 2026

Novo Nordisk's Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says

Proactive Investors

Novo Nordisk's (NYSE:NVO) oral version of its blockbuster weight-loss drug Wegovy continues to outpace its main competitor despite a slight weekly decline in prescriptions, according to Citi's latest tracking data. The bank's weekly prescription tracker, based on IQVIA data, showed Wegovy pill reaching approximately 137,000 total prescriptions in its 18th week on the US market, a 4% decline week on week.

Read full article arrow
News Thumbnail
1:00 AM | Sunday | May 17, 2026

Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?

The Motley Fool

After stealing the show with Zepbound, Eli Lilly could further gain an edge in the market with its latest weight loss treatment, retatrutide. In recent clinical trials, the drug has demonstrated that it can serve as a stronger diabetes and weight loss treatment than its predecessors, not to mention the competition.

Read full article arrow
News Thumbnail
11:00 AM | Saturday | May 16, 2026

Lilly, Caitlin Clark Foundation, and Musco Lighting open three community sports courts in Indianapolis, expanding year-round access for youth

PRNewsWire

Lilly to provide park and court to the City of Indianapolis as part of its 150th anniversary celebration INDIANAPOLIS, May 16, 2026 /PRNewswire/ -- The Caitlin Clark Foundation, in partnership with Eli Lilly and Company (NYSE: LLY) and Musco Lighting, has opened three new multi-sport community courts across Indianapolis—creating year-round access to safe, high-quality spaces for youth to play. These latest court openings include two courts at Indianapolis Public Schools—Clarence Farrington and Edison School of the Arts—and a public court at the corner of E.

Read full article arrow
News Thumbnail
12:31 PM | Friday | May 15, 2026

BIIB Advances Alzheimer's Disease Drug Despite Study Missing Main Goal

Zacks Investment Research

Biogen advances Alzheimer's drug diranersen to late-stage trials after a phase II study misses its main goal but shows cognitive and biomarker gains.

Read full article arrow
News Thumbnail
10:00 AM | Friday | May 15, 2026

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail
7:00 AM | Thursday | May 14, 2026

Lilly and UNICEF collaborate to give millions of children a healthier start

PRNewsWire

Six-year initiative to improve non-communicable disease prevention and care for children in low- and middle-income countries NEW YORK and INDIANAPOLIS, May 14, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and UNICEF USA announced today a collaboration aiming to improve non-communicable disease (NCD) prevention and care for children, reaching over 30 million young people and caregivers across 21 low- and middle-income countries. Marking its 150th anniversary, Lilly is committing $50 million to UNICEF USA, supporting UNICEF's efforts to strengthen primary healthcare systems to better prevent, detect and manage NCDs such as diabetes, congenital heart disease, sickle cell disease and respiratory illness in children and adolescents.

Read full article arrow
News Thumbnail
12:52 PM | Wednesday | May 13, 2026

Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead

Zacks Investment Research

LLY expands beyond tirzepatide with oral obesity pills and next-gen drugs like retatrutide to defend its lead in the booming weight-loss market.

Read full article arrow
News Thumbnail